News & Updates

Use of allopurinol 300 mg helps prevent the incidence of overall complications associated with liver cirrhosis, reports a study.

A 5-day course of oral amoxicillin-clavulanate performs just as wells as a 10-day course in the treatment of febrile urinary tract infection (fUTI) in children, a study has shown.

Stopping prescription benzodiazepine treatment may leave long-term users worse off, with a study finding increases in the risks of death and other unfavourable events.

Both vedolizumab and ustekinumab are safe to use in pregnant women with inflammatory bowel disease (IBD), as reported in a study.

Adding clarithromycin to standard of care appears to improve clinical response and reduce inflammation in patients with community-acquired pneumonia, as reported in the phase III ACCESS trial.

The addition of sotorasib to panitumumab significantly improves progression-free survival (PFS) in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (CRC) compared with the investigator’s choice of standard-of-care (SoC) treatment, according to the CodeBreaK 300 trial presented at ESMO Asia 2023.

Treatment with tiotropium appears to reduce the risk of clinically important deterioration (CID) in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD), including those with fewer respiratory symptoms, according to a study.